Sophiris Bio (NASDAQ:SPHS) Stock Price Down 15.4% ... An increase of 42% from the average daily volume of 1,359,925 shares. The stock had previously closed at $0.78. Several brokerages have recently commented on SPHS. HC Wainwright set a $2.80 target price on shares of Sophiris Bio and gave the company a “buy” rating in a report on Monday, October 21st. Are Sophiris Bio, Inc. (SPHS) Shares Headed For A Pullback ... Jan 13, 2020 · On Friday, shares of Sophiris Bio, Inc. (NASDAQ:SPHS) marked $0.53 per share versus a previous $0.63 closing price. With having a -16.10% loss, an insight into the fundamental values of Sophiris Bio, Inc., investors would also find a great ally in the technical patterns of the stock movements showed in stock charts. SPHS Institutional Ownership - Sophiris Bio, Inc. Stock
18 Nov 2019 Type of Stock On October 21, 2019, Sophiris Bio, Inc. (SPHS) (“ZIR”), and the issuers covered by the Zacks SCR Analysts in the Small-Cap
Mar 31, 2020 · That day the ROTH Capital set price target on the stock to $8. The stock was given Overweight rating by Piper Jaffray in its report released on August 30, 2016, the day when the price target on the stock was placed at 7. Maxim Group was of a view that SPHS is Buy in its latest report on August 10, 2016. Stifel thinks that SPHS is worth Hold rating. Do Analysts Recommend You Should Buy Sophiris Bio, Inc ... Mar 16, 2020 · Additionally, SPHS shares got another “Buy” rating from ROTH Capital, setting a target price of $8 on the company’s shares, according to the report published in September 15th, 2016. On August 30th, 2016, Piper Jaffray Initiated an Overweight rating and increased its price target to $7. Is A Downturn Overdue? Provention Bio Inc. (NASDAQ:PRVB ... Mar 12, 2020 · Their price target on the stock stands at $5. Rodman & Renshaw also rated SPHS as Initiated on March 13, 2017, with its price target of $6 suggesting that SPHS could surge by 92.92% from its current share price. Even though the stock has been trading at $0.58/share, analysts expect it to down by -60.30% to reach $3.25/share. Sophiris Bio, Inc. (SPHS) stock price, quote, history ... Find the latest Sophiris Bio, Inc. (SPHS) stock quote, history, news and other vital information to help you with your stock trading and investing.
SOPHIRIS BIO INC (SPHS) Stock Price, Quote, History & News ...
Sophiris Bio Inc., SPHS Quick Chart - (OTC) SPHS, Sophiris ... Headlines for Sophiris Bio Inc. (OTC:SPHS) News for Sophiris Bio Inc. Tuesday, July 09, 2019. 07:53 AM ET. Sophiris Bio stock price target cut to $4 from $6 at Maxim Group MarketWatch. Monday, June 25, 2018. 09:02 AM ET. Sophiris Bio shares plummet 46% on news of patient death in trial for prostate cancer drug MarketWatch. Sophiris Bio - SPHS - Stock Price & News | The Motley Fool
Sophiris Bio, Inc. is a clinical-stage biopharmaceutical company, which develops products for the treatment of urological diseases. It is currently developing PRX302 as a treatment for the symptoms of benign prostatic hyperplasia which is a non-cancerous enlargement of the prostate gland that causes a restriction in urine flow from the urethra resulting in lower urinary tract symptoms.
Sophiris Bio (SPHS) Stock Price History | wallmine Sep 19, 2018 · Sophiris Bio, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of products for the treatment of urological diseases. The firm develops PRX302 as a treatment for the symptoms of benign prostatic hyperplasia which is a non cancerous enlargement of the prostate gland that causes a restriction in urine flow from the urethra resulting in lower urinary tract SPHS - Sophiris Bio Inc., Stock Quote, Analysis, Rating ... SPHS has closed above the upper band by 32.2%. If price is in a uptrend band; this upward trend in price might continue. However a short term pullback inside the band is likely.Bollinger Bands are 48.8% narrower than normal. The narrow width of the bands suggests … SPHS - Sophiris Bio Stock Price - Barchart.com 60-Month Beta: Coefficient that measures the volatility of a stock's returns relative to the market (S&P 500). It is based on a 60-month historical regression of the return on the stock onto the return on the S&P 500. Price/Sales: Latest closing price divided by the last 12 months of revenue/sales per share.
In-depth view of key statistics and finances for SOPHIRIS BIO INC. (SPHS) on MSN Money.
SPHS | Complete Sophiris Bio Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. Sophiris Bio stock price target cut to $4 from $6 at SPHS Stock Price, Forecast & News (Sophiris Bio) | MarketBeat Researching Sophiris Bio (NASDAQ:SPHS) stock? View SPHS's stock price, price target, earnings, financials, forecast, insider trades, news, and SEC filings at MarketBeat. Sophiris Bio Inc. (SPHS) Analyst Research | Nasdaq Based on analysts offering 12 month price targets for SPHS in the last 3 months. The average price target is $ 0.00 with a high estimate of $ 0.00 and a low estimate of $ 0.00. Sign in to your SPHS Price Target and Analyst Ratings (Sophiris Bio ...
In-depth view of key statistics and finances for SOPHIRIS BIO INC. (SPHS) on MSN Money. SPHS - Sophiris Bio Stock Analyst Ratings - Barchart.com Analyst Ratings for Sophiris Bio (SPHS) provide recommendations made by outside industry experts. Barchart provides Analyst Ratings to give you another tool to gauge the possible future performance of a stock. Analyst Ratings are available for US and Canadian equities. Analyst Target Prices. The chart at the top shows a one-year chart HTBX Heat Biologics Inc. — Stock Price and Discussion ... Apr 03, 2020 · Market Data by Xignite and BATS BZX Real-Time Price. Securities products and services offered to self-directed investors through ST Invest, LLC. Member FINRA / SIPC. ST Invest is a wholly owned subsidiary of StockTwits, Inc. Investing in securities products involves risk,